IN8BIO, INC. (INAB) reporting calendar
IN8BIO, INC. files periodic reports with the SEC as INAB on Nasdaq. Atlas tracks 20 filed reports for this issuer, each linked to its original EDGAR accession.
- Next window
- 21 Jul 2026 – 24 Aug 2026
- Latest report
- 10-Q
- Period ended
- 31 Mar 2026
- Filed
- 7 May 2026
- Reports on record
- 20
How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 38 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.
Open INAB market profile
Latest filing on SEC EDGAR ↗
Biological Products, (No Diagnostic Substances) reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 10-Q | 31 Mar 2026 | 7 May 2026 | 37 days | 0001193125-26-212135 |
| 10-K | 31 Dec 2025 | 12 Mar 2026 | 71 days | 0001193125-26-104181 |
| 10-Q | 30 Sep 2025 | 6 Nov 2025 | 37 days | 0001193125-25-269447 |
| 10-Q | 30 Jun 2025 | 7 Aug 2025 | 38 days | 0000950170-25-105028 |
| 10-Q | 31 Mar 2025 | 7 May 2025 | 37 days | 0000950170-25-065609 |
| 10-K | 31 Dec 2024 | 13 Mar 2025 | 72 days | 0000950170-25-038738 |
| 10-Q | 30 Sep 2024 | 12 Nov 2024 | 43 days | 0000950170-24-125537 |
| 10-Q | 30 Jun 2024 | 8 Aug 2024 | 39 days | 0000950170-24-093943 |
| 10-Q | 31 Mar 2024 | 9 May 2024 | 39 days | 0000950170-24-056910 |
| 10-K | 31 Dec 2023 | 14 Mar 2024 | 74 days | 0000950170-24-031486 |
| 10-Q | 30 Sep 2023 | 9 Nov 2023 | 40 days | 0000950170-23-062018 |
| 10-Q | 30 Jun 2023 | 10 Aug 2023 | 41 days | 0000950170-23-041482 |
| 10-Q | 31 Mar 2023 | 12 May 2023 | 42 days | 0000950170-23-021507 |
| 10-K | 31 Dec 2022 | 30 Mar 2023 | 89 days | 0000950170-23-010997 |
| 10-Q | 30 Sep 2022 | 10 Nov 2022 | 41 days | 0000950170-22-024178 |
| 10-Q | 30 Jun 2022 | 12 Aug 2022 | 43 days | 0000950170-22-017132 |
| 10-Q | 31 Mar 2022 | 12 May 2022 | 42 days | 0000950170-22-009658 |
| 10-K | 31 Dec 2021 | 17 Mar 2022 | 76 days | 0000950170-22-004101 |
| 10-Q | 30 Sep 2021 | 10 Nov 2021 | 41 days | 0000950170-21-004129 |
| 10-Q | 30 Jun 2021 | 10 Sep 2021 | 72 days | 0000950170-21-001767 |
Source: SEC EDGAR company submissions for CIK 0001740279. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.